The Chemours Company (CC) vs Hawkins, Inc. (HWKN)
The Chemours Company and Hawkins, Inc. are both Specialty Chemicals companies. Hawkins, Inc. is the larger, with a market value of $2.6B against $2.1B — 1.2× the size. The Chemours Company has negative trailing earnings, so its P/E is not meaningful; Hawkins, Inc. trades at 33.2×. Hawkins, Inc. grew revenue faster over the last twelve months: 9.32% against −0.89%. Hawkins, Inc. has the higher net margin (7.29% vs −5.24%) and the higher return on invested capital (9.45% vs −2.22%). Both pay a dividend; The Chemours Company yields more (3.32% vs 1.01%). Across the 21 metrics below, Hawkins, Inc. leads on 15 and The Chemours Company on 6.
Valuation
Profitability
| Metric | CC | HWKN | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 15.28% | 22.30% | 29.23% |
| Operating margin | (1.93%) | 10.73% | 3.63% |
| Net margin | (5.24%) | 7.29% | 2.89% |
| Free cash flow margin | 3.76% | 8.40% | 3.78% |
| Return on equity | (318.32%) | 15.61% | 3.62% |
| Return on assets | (4.15%) | 8.08% | 0.35% |
| Return on invested capital | (2.22%) | 9.45% | 2.75% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack